61 articles · page 1 of 6
Written by : Ari Feinstein and Zoe E. Vikstrom HIKMA PHARMACEUTICALS USA INC. et al. v. AMARIN PHARMA, INC., et al. Jackson, J., delivered the opinion for a unanimous Court. Certiorari to the United States Court of Appeals for the Federal Circuit. Summary:…
In a closely watched dispute that sits at the intersection of patent validity, administrative review, and high-stakes smartphone litigation, the U.S. Supreme Court on November 17, 2025, declined to hear an appeal brought by Gesture Technology Partners…
Written by : Ian W. Gillies The trademark attorney Thomas D. Foster has found himself in ongoing legal star wars to register US SPACE FORCE as his personal trademark covering coins, jewelry, watches, license plate holders, toys, and other everyday goods.…
Written by : Ari Feinstein and Joseph Mallon, Ph.D. On October 11, 2024, Edwards [1] filed a petition for a writ of certiorari with the U.S. Supreme Court. [2] The question presented, as framed by Edwards, is: “Whether, under Hatch-Waxman’s…
The U.S. Supreme Court recently chose not to review a substantial $502.8 million jury verdict in favor of VirnetX , a patent-licensing firm, in its long-standing legal battle against tech giant Apple over internet-security patents. This decision…
The recent judgment in Amgen v Sanofi by the United States Supreme Court has generated significant attention within the legal and patent communities. The ruling addresses the crucial issue of enablement requirement, marking the first time in several…
The Supreme Court is the highest court in the United States, and its decisions have a significant impact on the country's legal system. Every year, the Court receives thousands of petitions asking it to review lower court decisions, but it only agrees…
Written by : Ari Feinstein & Agnes Juang, Ph.D. On March 29, 2023, the Solicitor General of the United States asked the Supreme Court to review a Federal Circuit judgment in a Hatch-Waxman case between Teva and GSK. In its decision below, the Federal…
Yesterday, the United States Supreme Court heard arguments in a trademark dispute between whiskey maker Jack Daniel's and VIP Products, the manufacturer of a dog toy that parodies the whiskey's bottle and label. The crux of the issue is whether VIP…
Written by : Philip M. Nelson In 2023, the U.S. Supreme Court will hear oral argument in Amgen Inc. v. Sanofi to decide whether an inventor must describe every example in a category to get an enforceable patent for that category. Must a patent simply give…
In March and April, we plan to release our Patent Intelligence Report and Trademark Intelligence Report, which will cover patent and trademark prosecution in the past five years. These two popular IP practice areas typically cover many more law firms and…
Most of the community involved in life science litigation and pharmaceutical companies, thought they saw the end of the long-fought battle between Amgen and Sanofi in 2021 with the CAFC decision . As a result, at the time, it was said that the attorney…
